| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.042 | 0.7 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |